EXL loses insurance and healthcare head to Hexaware CEO role
EXL Service Holdings, the New York-listed data and AI firm, has confirmed that Vivek Jetley, president and head of its Insurance, Healthcare and Life Sciences division, will leave on 26 October 2026 to become chief executive of Hexaware Technologies. Jetley joined EXL nearly two decades ago and is credited with building out its analytics capability before taking ownership of its two largest vertical markets by revenue.
The announcement is routine in form but strategically weighted in substance. Insurance and healthcare together represent EXL's deepest client relationships and the sectors most exposed to the wave of AI-driven process automation currently reshaping claims handling, underwriting, and payer operations. Losing the executive who architected those practices introduces execution risk precisely as competitors including Genpact, WNS and Concentrix are accelerating their own AI-services propositions in the same verticals.
A test of bench depth
EXL chairman and CEO Rohit Kapoor moved quickly to frame the departure as non-disruptive, saying the company has "a fantastic leadership team and a deep bench of talent" and will "not miss a beat in executing on our data and AI strategy." That phrasing signals to investors that no external search is imminent, and that an internal succession is likely already identified. Jetley, for his part, confirmed he will remain in post during a transition period stretching to late October, reducing the window of uncertainty.
For Hexaware, the appointment is the more consequential signal. Hexaware, backed by Carlyle, has been positioning itself for a renewed public markets push after its 2023 Mumbai IPO revival. Installing a sector-specialist with deep insurance and healthcare credentials suggests the company is targeting exactly the vertical AI-services market that EXL, Genpact and Infosys BPM have been building for years. That competitive dynamic matters beyond a single C-suite move: it compresses margins across the entire data-and-AI services tier as more well-capitalised platforms chase the same enterprise buyers.
Cross-sector read-across
The broader implication sits at the intersection of enterprise AI adoption and professional services capital allocation. Insurers and healthcare payers are among the heaviest buyers of AI-augmented analytics services globally, driven by regulatory pressure on loss ratios and the accelerating cost of clinical administration. As that spend grows, the firms managing it are themselves becoming strategic assets. Carlyle's stewardship of Hexaware and its apparent intent to field a credible insurance-and-health specialist signals that private equity is treating AI-services verticals with the same capital intensity it once reserved for software platforms.
For cross-sector investors, the Hexaware move is worth tracking as a proxy for where institutional capital believes AI-services monetisation is most durable. Healthcare administration and insurance underwriting are compliance-heavy, data-rich and resistant to commoditisation, making them more defensible than horizontal BPO work. If Hexaware follows with a secondary public offering or strategic acquisition in the health-tech space under Jetley's leadership, that would confirm the thesis that domain-specialist AI services are attracting a premium that generalist outsourcers cannot easily replicate.
EXL, meanwhile, trades on its own AI-transformation narrative. The near-term test is whether the succession holds client confidence through contract renewal cycles in Q4 2026 and into fiscal 2027.